These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21143008)

  • 1. Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.
    Floreani A; Navaglia F; Rizzotto ER; Basso D; Chiaramonte M; Padoan A; Petridis I; Cazzagon N; Testa R; Marra M; Plebani M
    Clin Chem Lab Med; 2011 Feb; 49(2):197-206. PubMed ID: 21143008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.
    Bozzini C; Campostrini N; Trombini P; Nemeth E; Castagna A; Tenuti I; Corrocher R; Camaschella C; Ganz T; Olivieri O; Piperno A; Girelli D
    Blood Cells Mol Dis; 2008; 40(3):347-52. PubMed ID: 18164223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.
    Tessitore N; Girelli D; Campostrini N; Bedogna V; Pietro Solero G; Castagna A; Melilli E; Mantovani W; De Matteis G; Olivieri O; Poli A; Lupo A
    Nephrol Dial Transplant; 2010 Dec; 25(12):3996-4002. PubMed ID: 20538788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
    Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome.
    Luque-Ramírez M; Álvarez-Blasco F; Alpañés M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2011 Mar; 96(3):846-52. PubMed ID: 21209031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy.
    Barosi G; Salvaneschi L; Grasso M; Martinetti M; Marchetti M; Bodini U; Reggiani A; D'Agostino F; Nalli G; Degiuli A; De Silvestri A; Arbustini E
    Haematologica; 2002 May; 87(5):472-8. PubMed ID: 12010659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry analysis of hepcidin peptides in experimental mouse models.
    Tjalsma H; Laarakkers CM; van Swelm RP; Theurl M; Theurl I; Kemna EH; van der Burgt YE; Venselaar H; Dutilh BE; Russel FG; Weiss G; Masereeuw R; Fleming RE; Swinkels DW
    PLoS One; 2011 Mar; 6(3):e16762. PubMed ID: 21408141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.
    Kemna EH; Tjalsma H; Podust VN; Swinkels DW
    Clin Chem; 2007 Apr; 53(4):620-8. PubMed ID: 17272487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and validation of a high-throughput matrix-assisted laser desorption ionization time-of-flight mass spectrometry method for quantification of hepcidin in human plasma.
    Anderson DS; Kirchner M; Kellogg M; Kalish LA; Jeong JY; Vanasse G; Berliner N; Fleming MD; Steen H
    Anal Chem; 2011 Nov; 83(21):8357-62. PubMed ID: 21958231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].
    Qin Y; Liu H; Ruan S; Cai YF; You XF; Song GQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):758-61. PubMed ID: 22339912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.